Fundraising FoxCathay Health — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.
BiotechHealthtechMedical DevicesMunich, DE
Evis Hursever(Executive Officer)Wesley McConnell(Executive Officer)inMichael Stella(Executive Officer, Director)William Hawkins(Executive Officer)
BoardMichael Beecham(Director)Andrew Kozlov(Director)
PartnerEric De La Fortelle· solo GP
Co-investorsDCVC (Data Collective)Monograph Capital Partners4BIO CapitalDigitalis Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.